97 related articles for article (PubMed ID: 2572655)
1. [Clinical evaluation of serum CA130 in patients with lung cancer].
Matsubara Y; Shiota T; Ishida H; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1557-65. PubMed ID: 2572655
[TBL] [Abstract][Full Text] [Related]
2. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
Sakahara H; Saga T; Endo K; Kousaka T; Hosono M; Kobayashi H; Shirato M; Konishi J
Br J Cancer; 1993 Nov; 68(5):920-5. PubMed ID: 8217607
[TBL] [Abstract][Full Text] [Related]
3. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of sialyl SSEA-1 antigen in patients with lung cancer].
Shiota T; Matsubara Y; Ikeda S; Ishida H; Katsura A; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1067-73. PubMed ID: 2570808
[TBL] [Abstract][Full Text] [Related]
5. [The significance of CA-50, SLX and ST-439 in lung cancer].
Hayasaka S; Takada M; Shinohara T; Imamura S; Takifuji N; Kudoh S; Matsui K; Kusunoki Y; Masuda N; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):802-7. PubMed ID: 1681128
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
7. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
[TBL] [Abstract][Full Text] [Related]
8. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
9. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of serum sialyl Lewis X-i (SLX) in diffuse panbronchiolitis].
Noguchi M; Nakatani T; Chohnabayashi N; Nakamori Y; Nakata K; Matsushita H; Tanimoto H
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):317-25. PubMed ID: 2575680
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of CA130 in fetal tissues, and in normal and neoplastic tissues of the female genital tract.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Sagawa N; Kobayashi F; Mori T; Saga T; Endo K
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):379-87. PubMed ID: 2099733
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].
Tanaka T; Iwasaka T; Hayashi Y; Hachisuga T; Yokoyama M; Ohkuma Y; Matsuo N; Fukuda K; Sugimori H
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1157-61. PubMed ID: 1975831
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of the sialyl SSEA-1 antigen and CEA in the histology of malignant mesothelioma, with special reference to adenocarcinoma of the lung].
Kishimoto T; Okada K; Shimamoto F; Sato T; Ono T
Gan No Rinsho; 1988 Nov; 34(14):1951-5. PubMed ID: 2462647
[TBL] [Abstract][Full Text] [Related]
16. [Value of SLX and CA19-9 in the serum and tissue in colorectal cancer including the relation to Lewis blood type].
Igarashi K
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2394-403. PubMed ID: 2574243
[TBL] [Abstract][Full Text] [Related]
17. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
19. [The present and the future of tumor markers].
Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):883-9. PubMed ID: 1680941
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
